Responding to President Obama’s call for “a cure for cancer in our time,” the Pharmaceutical Research and Manufacturers of America recently delivered a new report on drugs in the research pipeline for cancer.
Responding to President Obama's call for "a cure for cancer in our time," the Pharmaceutical Research and Manufacturers of America recently delivered a new report on drugs in the research pipeline for cancer. The report shows that America's pharmaceutical research and biotechnology companies are testing a record 861 new cancer medicines and vaccines. The drugs listed in the report are being tested in human clinical trials or are awaiting approval by the US Food and Drug Administration.
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer
Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population.